All Stories

  1. Ceramides accumulation and complement activation in patients with EMRN
  2. Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases
  3. Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses
  4. Corrigendum to “Galabiosylceramide is present in human cerebrospinal fluid”
  5. Cerebrospinal Fluid Profiles in Parkinson’s Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment
  6. Review article for the close relationship between neuroinflammation and glycosphingolipids
  7. Galabiosylceramide is present in human cerebrospinal fluid
  8. Clioquinol kills astrocyte-derived KT-5 cells by the impairment of the autophagy–lysosome pathway
  9. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome
  10. cross-talk between Trk neurotrphin receptor and innate immunity
  11. Variants in saposin D domain of prosaposin gene linked to Parkinson’s disease
  12. Mazaticol for Treating Parkinson
  13. Better neuroradiological approach for the diagnosis of early-stage Parkinson's disease patients
  14. Piroheptine for Treating Parkinson
  15. Altered regulation of serum lysosomal acid hydrolase activities in Parkinson's disease: A potential peripheral biomarker?
  16. A Patient With Thiamine Deficiency Exhibiting Muscle Edema Suggested by MRI
  17. Changes in Serial D-Dimer Levels Predict the Prognoses of Trousseau's Syndrome Patients
  18. Anti-GM1 ganglioside antibodies modulate membrane-associated sphingomyelin metabolism by altering neutral sphingomyelinase activity
  19. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study
  20. Usefulness of combining 123 I-FP-CIT-SPECT striatal asymmetry index and cardiac 123 I-metaiodobenzylguanidine scintigraphy examinations for diagnosis of parkinsonisms
  21. MR neurography for the evaluation of CIDP
  22. Differentiation of cancer from atrial fibrillation in patients with acute multifocal stroke
  23. encephalomyeloradiculoneuropathy patient showing anti-neutral glycolipids antibodies and epilepsy
  24. brain abscess
  25. Retrospective analysis of parkinsonian patients exhibiting normal 123I-MIBG cardiac uptake
  26. Voriconazole-responsive Disseminated Nodular Lesions on Spinal MRI
  27. Neurotropin promotes NGF signaling through interaction of GM1 ganglioside with Trk neurotrophin receptor in PC12 cells
  28. Hypertrophic pachymeningitis and encephalitis in a patient with relapsing polychondritis
  29. An update on diagnostic imaging studies for viral encephalitis
  30. Winged scapula in patients with myotonic dystrophy type 1
  31. Extracorporeal Aβ removal system (EARS) for Alzheimer's disease therapy: Novel devices with fragments of hollow fibers removed Aβ effectively both in vitro and in vivo
  32. Glycobiology and neurological disorders
  33. Transient Splenial Lesion of the Corpus Callosum in H1N1 Influenza Virus-Associated Encephalitis/Encephalopathy
  34. Neurotrophin Levels in Cerebrospinal Fluid of Adult Patients with Meningitis and Encephalitis
  35. Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin
  36. Novel therapeutic approach for Alzheimer’s disease by removing amyloid β protein from the brain with an extracorporeal removal system
  37. Muscle MRI in Myotonic Dystrophy Type 1 with Foot Drop
  38. Clioquinol inhibits NGF-induced Trk autophosphorylation and neurite outgrowth in PC12 cells
  39. Toward the novel method of treatment for Alzheimer's disease: Extra-corporeal Aβ removal system (EARS)
  40. Electroretinograms in three cases of Creutzfeldt-Jakob disease with visual disturbances
  41. Acute Autonomic, Sensory and Motor Neuropathy: Successful Treatment with IVIg
  42. β-amyloid (25–35) enhances lipid metabolism and protein ubiquitination in cultured neurons
  43. Role of Glycosphingolipids and Therapeutic Perspectives on Alzheimers Disease
  44. Postinfectious Myeloradiculoneuropathy With Cranial Nerve Involvements Associated With Human Herpesvirus 7 Infection
  45. Impairment of Trk-Neurotrophin Receptor by the Serum of a Patient With Subacute Sensory Neuropathy
  46. Abnormal intracellular trafficking of high affinity nerve growth factor receptor, Trk, in stable transfectants expressing presenilin 1 protein
  47. Tyrosine phosphorylation of the catalytic subunit p110 of phosphatidylinositol-3 kinase induced by HMG-CoA reductase inhibitor inhibits its kinase activity in L6 myoblasts
  48. Biological Implication of the Membrane Rafts in Neuronal Cells
  49. Spinal Cavitous Hemorrhagic Infarction with Abdominal Aortic Aneurysm
  50. HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, Trk, and morphological differentiation with fatal outcome in PC12 cells
  51. Posterior Thoracic Spinal Cord Infarction: Complication of Thoracoabdominal Aortic Aneurysm
  52. MRI findings of benign monomelic amyotrophy of lower limb
  53. Role of tyrosine phosphorylation of phospholipase C γ1 in the signaling pathway of HMG-CoA reductase inhibitor-induced cell death of L6 myoblasts
  54. Involvement of tyrosine phosphorylation in HMG-CoA reductase inhibitor-induced cell death in L6 myoblasts
  55. Expression of GDNF receptor (RET and GDNFR-α) mRNAs in the spinal cord of patients with amyotrophic lateral sclerosis
  56. Influence of endogenous GM1 ganglioside on TrkB activity, in cultured neurons
  57. HMG-CoA reductase inhibitor-induced L6 myoblast cell death: involvement of the phosphatidylinositol 3-kinase pathway
  58. Differential signaling cascade of MAP kinase and S6 kinase depends on 3′,5′-monophosphate concentration in Schwann cells: correlation to cellular differentiation and proliferation
  59. NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule:
  60. GM1 gangliosidosis type 3 with severe jaw-closing impairment
  61. Chorea-acanthocytosis with polyclonal antibodies to ganglioside GM1
  62. Discovery of ganglioside GM1 for normal function of Trk neurotrophin receptor in neuronal cells.
  63. 1-Methyl-4-phenylpyridinum kills differentiated PC12 cells with a concomitant change in protein phosphorylation
  64. Abundant but Inactive-state gpl40prototrkIs Expressed in Neuroblastomas of Patients with Good Prognosis
  65. The Effect of the B Subunit of Cholera Toxin on the Action of Nerve Growth Factor on PC12 Cells
  66. A microassay for acid β-galactosidase activity toward asialofetuin
  67. Application of a GM1 ganglioside β-galactosidase microassay method to diagnosis of GM1 gangliosidosis
  68. A fluorometric microassay procedure for monitoring the enzymatic activity of GM1-ganglioside β-galactosidase by use of high-performance liquid chromatography